Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2008-08-25 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CONCHES-SUR-GONDOIRE (77600), Seine-et-Marne
PHARMACIE DU LAURENCON : revenue, balance sheet and financial ratios
PHARMACIE DU LAURENCON is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CONCHES-SUR-GONDOIRE (77600),
this company of category PME
shows in 2018 a revenue of 815 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU LAURENCON (SIREN 507607471)
Indicator
2023
2022
2021
2020
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
814 596 €
846 545 €
873 215 €
Net income
100 861 €
157 514 €
78 758 €
81 117 €
44 651 €
63 331 €
61 739 €
EBITDA
N/C
N/C
N/C
N/C
85 135 €
100 264 €
97 315 €
Net margin
N/C
N/C
N/C
N/C
5.5%
7.5%
7.1%
Revenue and income statement
In 2023, PHARMACIE DU LAURENCON generates positive net income of 101 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 62 k€ -> 101 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
100 861 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 12%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
11.952%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
72.456%
Solvency indicators evolution PHARMACIE DU LAURENCON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2020
2021
2022
2023
Debt ratio
133.836
99.779
75.88
45.484
30.706
18.488
11.952
Financial autonomy
32.409
37.34
43.293
49.839
54.659
63.891
72.456
Repayment capacity
5.463
4.57
4.832
None
None
None
None
Cash flow / Revenue
7.353%
8.212%
6.949%
None%
None%
None%
None%
Sector positioning
Debt ratio
11.952023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent
In 2023, the debt ratio of PHARMACIE DU LAURENCON (11.95) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
72.46%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent+12 pts over 3 years
In 2023, the financial autonomy of PHARMACIE DU LAURENCON (72.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU LAURENCON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2020
2021
2022
2023
Operating WCR
40 439 €
79 584 €
25 660 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
25
33
28
0
0
0
0
Customer payment term (days)
2
5
0
0
0
0
0
Supplier payment term (days)
78
96
82
0
0
0
0
Positioning of PHARMACIE DU LAURENCON in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DU LAURENCON is estimated at
1 190 106 €
(range 723 760€ - 1 673 023€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
723k€1190k€1673k€
1 190 106 €Range: 723 760€ - 1 673 023€
NAF 5 année 2023
Valuation method used
Net Income Multiple
100 861 €
×
11.8x
=1 190 107 €
Range: 723 761€ - 1 673 023€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU LAURENCON with other companies in the same sector:
Frequently asked questions about PHARMACIE DU LAURENCON
What is the revenue of PHARMACIE DU LAURENCON ?
The revenue of PHARMACIE DU LAURENCON in 2018 is 815 k€.
Is PHARMACIE DU LAURENCON profitable?
Yes, PHARMACIE DU LAURENCON generated a net profit of 101 k€ in 2023.
Where is the headquarters of PHARMACIE DU LAURENCON ?
The headquarters of PHARMACIE DU LAURENCON is located in CONCHES-SUR-GONDOIRE (77600), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE DU LAURENCON ?
The tax return of PHARMACIE DU LAURENCON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU LAURENCON operate?
PHARMACIE DU LAURENCON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart